GSK beat fourth-quarter profit and sales forecasts helped by sales of its shingles vaccine and unveiled an upbeat forecast for 2023. Meanwhile, Novartis said it’s full-year core operating income was broadly flat, and below expectations, at $16.7 billion https://t.co/rckUBnxFEr pic.twitter.com/CccKRFliTB— Reuters (@Reuters) February 1, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


